Y. Matsumoto

Debate on the treatment of multiple sclerosis: Experience from an intractable multiple sclerosis case with rebound syndrome after fingolimod cessation

K. Fujihara, T. Misu, M. Aoki, 2019, Clinical and Experimental Neuroimmunology.

Distinctive lesions of brain MRI between MOG-antibody-associated and AQP4-antibody-associated diseases

K. Fujihara, T. Misu, S. Mugikura, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview

K. Fujihara, T. Misu, S. Nishiyama, 2018 .

MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review

T. Misu, K. Kaneko, Toshiyuki Takahashi, 2022, Frontiers in Neurology.

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin

K. Fujihara, Toshiyuki Takahashi, Teiji Yamamoto, 2018, Multiple sclerosis journal - experimental, translational and clinical.

Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.

Y. Itoyama, K. Fujihara, H. Lassmann, 2021, Brain : a journal of neurology.

Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease

K. Fujihara, T. Misu, I. Nakashima, 2019, Journal of Neuroimmunology.

Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances

K. Fushimi, K. Fujihara, T. Misu, 2023, Journal of the Neurological Sciences.

Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.

K. Fujihara, T. Misu, H. Kuroda, 2023, Brain : a journal of neurology.

Humanized-Aquaporin-4-Expressing Rat Created by Gene-Editing Technology and Its Use to Clarify the Pathology of Neuromyelitis Optica Spectrum Disorder

T. Misu, Y. Takai, Y. Miyasaka, 2024, International journal of molecular sciences.